To Screen or Not to Screen? Office of Inspector General ("OIG") Updates Special Advisory Bulletin on Exclusion from Participation in Federal Health Care Programs

FDA Announces Implementation of "Remote Interactive Evaluations" of Drug Manufacturing Establishments and Biomedical Research

Life Sciences 2021 Guide